A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

for the PROMOTE Consortium

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: We designed a prospective feasibility study to assess the 5x-multiplier (5x) calculation (eg, 3 pills in last 24 hours × 5 = 15) to standardize discharge opioid prescriptions compared to usual care. Methods: Faculty-based surgical teams volunteered for either 5x or usual care arms. Patients undergoing inpatient (≥ 48 hours) surgery and discharged by surgical teams were included. The primary end point was discharge oral morphine equivalents. Secondary end points were opioid-free discharges and 30-day refill rates. Results: Median last 24-hour oral morphine equivalents was similar between arms (7.5 mg 5x vs 10 mg usual care, P = .830). Median discharge oral morphine equivalents were less in the 5x arm (50 mg 5x vs 75 mg usual care, P < .001). Opioid-free discharges included 33.5% 5x vs 18.0% usual care arm patients (P < .001). Thirty-day refill rates were similar (15.3% 5x vs 16.5% usual care, P = .742). Conclusion: The 5x-multiplier was associated with reduced opioid prescriptions without increased refills and can be feasibly implemented across a diverse surgical practice.

Original languageEnglish (US)
Pages (from-to)51-57
Number of pages7
JournalSurgery Open Science
Volume9
DOIs
StatePublished - Jul 2022

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients'. Together they form a unique fingerprint.

Cite this